computer software prism 4.0c for macintosh (GraphPad Software Inc)
GraphPad Software Inc is a verified supplier 
90
Structured Review
GraphPad Software Inc
computer software prism 4.0c for macintosh
Computer Software Prism 4.0c For Macintosh, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer+software+prism+4%2E0c+for+macintosh/computer+software+prism+4+0c+for+macintosh/pm23869543-36-8-14
Average 90 stars, based on 1 article reviews
Computer Software Prism 4.0c For Macintosh, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/computer+software+prism+4%2E0c+for+macintosh/computer+software+prism+4+0c+for+macintosh/pm23869543-36-8-14
Average 90 stars, based on 1 article reviews
computer software prism 4.0c for macintosh - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Software:Article Title: The serine racemase mRNA is expressed in both neurons and glial cells of the rat retina. Article Snippet: The results of the measurements of the Article Title: Balancing potential risks and benefits of hemoglobin-based oxygen carriers. Article Snippet: Hemoglobin-based oxygen carriers (HBOCs) are thought to have an adverse risk:benefit profile when compared to that of transfusing stored red blood cells (RBCs).. However, there are clinical circumstances when RBC transfusion is not an option (e.g., patient refusal, unavailability owing to issues of compatibility or remote location).. For these circumstances assessment of the risks of an HBOC should be compared to the risks of untransfused acute anemia. Comparison:Article Title: The serine racemase mRNA is expressed in both neurons and glial cells of the rat retina. Article Snippet: The results of the measurements of the Article Title: Balancing potential risks and benefits of hemoglobin-based oxygen carriers. Article Snippet: Hemoglobin-based oxygen carriers (HBOCs) are thought to have an adverse risk:benefit profile when compared to that of transfusing stored red blood cells (RBCs).. However, there are clinical circumstances when RBC transfusion is not an option (e.g., patient refusal, unavailability owing to issues of compatibility or remote location).. For these circumstances assessment of the risks of an HBOC should be compared to the risks of untransfused acute anemia. |